# Anti-Tuberculosis Drugs

## Anti-Mycobacterial Agents General Principles
* 3 Important organisms
  * Mycobacteria Tuberculosis
  * Mycobacterium Avium Complex
  * Mycobacterium Leprae
* How is Mycobacteria different?
  * Cell wall
    * Mycolic acid (Long chain fatty acids)
    * Arabinogalactan
    * Peptidoglycan
* How to kill Mycobacteria?
  * **Inhibit Cell wall synthesis**
    * **Inhibit Mycolic acid synthesis**: Isoniazid
    * **Inhibit Arabinogalactan polymerization**: Ethambutol
  * **Inhibit Transcription**
    * **Inhibit mRNA synthesis**: Rifampin
  * **Inhibit Protein Synthesis**: Aminoglycosides (Streptomycin)
  * **Inhibit new base synthesis**
    * **Inhibit folic acid synthesis**: SMX-TMP, Dapsone
  * **Inhibit DNA unwinding**: Fluoroquinolone
  * Unknown: Pyrazinamide

## Anti-Mycobacterial TB

**Rifampin & Rifabutin**
* MOA: inhibits **bacterial DNA-dependent RNA polymerase**
* Use:
  * Mycobacteria (TB, Leprosy)
  * Haemophilus influenza B Prophylaxis
  * Neisseria Meningitis Prophylaxis
* **Rifabutin**: Cousin with less Drug interactions- Preferred in HIV patients
* Side Effects:
  * Heme: Thrombocytopenia, leukopenia, anemia. Hyperbilirubinemia
  * Renal: Nephritis and proteinuria
  * **Red-orange color excreted fluids** (urine sweat, tears)
  * **Induce CYP 450 - decreases effectiveness of PO contraceptives**
* Resistance: Mutations in binding to RNA Polymerase

**Isoniazid (INH)**
* MOA: Inhibits mycolic acid synthesis
* Use:TB
* Metabolism
  * **"Histone Acetylation"**
  * Patients can be slow or fast Acetylators
* Side Effects:
  * **B6 Neuropathy**
  * Seizures (related to B6 Deficiency)
  * **Sideroblastic Anemia**
  * **Hepatotoxicity**
  * **Anion gap metabolic acidosis** (MUD PIILES)
  * **Drug induced Lupus - Anti-Histone antibodies**
* Resistance
  * INH is processed by **intracellular catalase peroxidase**
    * Resistance is decreased activity of this enzyme

*Side Note: Drug Induced Lupus (Hydralazine, Isoniazid, Procainamide)*

**Pyrazinamide**
* MOA: Unknown - Works in acidic environment (Phagolysosomes)
* Use: Part of RIPE
* Side Effects: Hepatotoxic

**Ethambutol**
* MOA:
* **Inhibit Arabinosyl transferase** which polymerizes arabinogalactan
  * Carbohydrate Part of TB cell wall
* Use: Part of RIPE
* Side Effects: **Optic Neuropathy - Red/Green color blindness**

**2nd line Agents**
* Aminoglycosides (Streptomycin)
* Fluoroquinolones (Ciprofloxacin, Levofloxacin)

**3rd line Agents**
* P-Aminosalicylic acid (Blocks folic acid)
* Ethionamide (Blocks mycolic acid)
* Cycloserine (Inhibits cell wall)

## Anti-Mycobacterium Leprae & Mycobacterium Avium Complex Agents

### Mycobacterium Leprae (Leprosy)
**Dapsone**
* MOA:
  * Folic acid antagonist
* Use
  * **Leprosy** both types
  * **PCP if patient has sulfa allergy**
* Side Effects:
  * Hemolysis with G6PD deficiency

**Other Drugs used for Leprosy**
* Rifampin
* Clofazimine

### Mycobacterium Avium Complex (MAC)
* AIDS defining illness
* Need to **prophylax HIV patients if CD4< 50**
* Drugs used for MAC
  * **Multi drug treatment**
  * **Azithromycin 1st line**
  * Clarithromycin
  * Ethambutol
  * Rifaputin

## Disease Summary - Mycobacteria

**Active Mycobacterium Tuberculosis**
* Be Aware of Directly Observed Treatment (DOT)
* **1st line**
  * RIPE
* **MDR**
  * High dose RIPE
  * Aminoglycosides X
  * Fluoroquinolone
* **XDR (Extra resistant)**
  * Ethionamide
  * Cycloserine
  * P-Aminosalicylic acid

**Mycobacterium Avium Complex (MAC)**
* 1st: Azithromycin
* 2nd: Ethambutol, Rifabutin

**Mycobacterium Leprae (Leprosy)**
* **Tuberculoid type (Th1)**
  * *Dapsone* + Rifampin
* **Lepromatous type (Th2)**
  * Dapsone + Rifampin + Clofazimine
